Literature DB >> 12675511

Thrombin signaling in the brain: the role of protease-activated receptors.

Hong Wang1, Georg Reiser.   

Abstract

Signaling by the protease thrombin has started to be appreciated in cell biology, especially since the gene for protease-activated receptor-1 (PAR-1) has been cloned. Apart from the central role of thrombin in blood coagulation and wound healing, thrombin also regulates cellular functions in a large variety of cells through PAR-1, PAR-3 and PAR-4. Receptors are activated by a proteolytic cleavage mechanism via G protein-coupled signaling pathways. Accumulating evidence shows that thrombin changes the morphology of neurons and astrocytes, induces glial cell proliferation, and even exerts, depending on the concentration applied, either cytoprotective or cytotoxic effects on neural cells. These effects may be mediated, through either distinct or overlapping signal transduction cascades, by activation of PARs. This review focuses on the underlying signaling events initiated by thrombin in neuronal and glial cells, to summarize our understanding of the intracellular signaling machinery linking thrombin receptors to their potential physiological and pathological functions in the CNS.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12675511     DOI: 10.1515/BC.2003.021

Source DB:  PubMed          Journal:  Biol Chem        ISSN: 1431-6730            Impact factor:   3.915


  42 in total

1.  Protease-activated receptor 1 (PAR1) coupling to G(q/11) but not to G(i/o) or G(12/13) is mediated by discrete amino acids within the receptor second intracellular loop.

Authors:  Kelly L McCoy; Stefka Gyoneva; Christopher P Vellano; Alan V Smrcka; Stephen F Traynelis; John R Hepler
Journal:  Cell Signal       Date:  2012-01-28       Impact factor: 4.315

2.  Proteinase-activated receptor-1 and -2 induce the release of chemokine GRO/CINC-1 from rat astrocytes via differential activation of JNK isoforms, evoking multiple protective pathways in brain.

Authors:  Yingfei Wang; Weibo Luo; Georg Reiser
Journal:  Biochem J       Date:  2007-01-01       Impact factor: 3.857

3.  Astrocytic control of synaptic NMDA receptors.

Authors:  C Justin Lee; Guido Mannaioni; Hongjie Yuan; Dong Ho Woo; Melissa B Gingrich; Stephen F Traynelis
Journal:  J Physiol       Date:  2007-04-05       Impact factor: 5.182

4.  The Molecular Mechanisms that Promote Edema After Intracerebral Hemorrhage.

Authors:  Daniel Bodmer; Kerry A Vaughan; Brad E Zacharia; Zachary L Hickman; E Sander Connolly
Journal:  Transl Stroke Res       Date:  2012-04-12       Impact factor: 6.829

5.  Excitatory and Mitogenic Signaling in Cell Death, Blood-brain Barrier Breakdown, and BBB Repair after Intracerebral Hemorrhage.

Authors:  Da-Zhi Liu; Frank R Sharp
Journal:  Transl Stroke Res       Date:  2012-03-15       Impact factor: 6.829

Review 6.  The Neuro-Immune-Regulators (NIREGs) Promote Tissue Resilience; a Vital Component of the Host's Defense Strategy against Neuroinflammation.

Authors:  Yosra Bedoui; Jim W Neal; Philippe Gasque
Journal:  J Neuroimmune Pharmacol       Date:  2018-06-16       Impact factor: 4.147

7.  Thrombin-promoted release of UDP-glucose from human astrocytoma cells.

Authors:  S M Kreda; L Seminario-Vidal; C van Heusden; E R Lazarowski
Journal:  Br J Pharmacol       Date:  2008-01-21       Impact factor: 8.739

8.  Microarray analysis of prothrombin knockdown in zebrafish.

Authors:  Kenneth R Day; Pudur Jagadeeswaran
Journal:  Blood Cells Mol Dis       Date:  2009-05-13       Impact factor: 3.039

9.  Src kinase inhibition decreases thrombin-induced injury and cell cycle re-entry in striatal neurons.

Authors:  Da-Zhi Liu; Xi-Yuan Cheng; Bradley P Ander; Huichun Xu; Ryan R Davis; Jeffrey P Gregg; Frank R Sharp
Journal:  Neurobiol Dis       Date:  2008-02-09       Impact factor: 5.996

10.  Experimental study on the PAR-1 expression around hemotoma following intracerebral hemorrhage in rats.

Authors:  Jingxia Guan; Shenggang Sun; Xuebing Cao; Zhibin Chen
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2004
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.